- Home
- MOMO vs SVRA Comparison
MOMO vs SVRA Comparison
Compare MOMO & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOMO | SVRA |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | MOMO | SVRA |
|---|---|---|
| Price | $5.86 | $4.97 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $7.33 |
| AVG Volume (30 Days) | 627.6K | ★ 1.4M |
| Earning Date | 03-18-2026 | 03-13-2026 |
| Dividend Yield | ★ 4.85% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $430.87 |
| P/E Ratio | $10.60 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.13 | $1.89 |
| 52 Week High | $9.22 | $7.01 |
Technical Indicators
Market Signals| Indicator | MOMO | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 36.65 |
| Support Level | N/A | $3.36 |
| Resistance Level | $7.14 | $6.10 |
| Average True Range (ATR) | 0.18 | 0.27 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 0.10 | 6.19 |
Price Performance
Historical ComparisonAbout MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).